Applied DNA Sciences Earnings Preview

Applied DNA Sciences APDN announces its next round of earnings this Thursday, December 17. Here is Benzinga's everything-that-matters guide for this Thursday's Q4 earnings announcement.

Net Income, Earnings, And Earnings Per Share

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Wall Street analysts see Applied DNA Sciences reporting a loss of $0.52 per share on revenue of $710.00 thousand. Applied DNA Sciences reported a loss of $1.44 when it published results during the same quarter last year. Sales in that period totaled $1.70 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

The analyst consensus estimate would represent a 63.89% increase in the company's EPS figure. Revenue would have fallen 58.24% from the same quarter last year. Here is how the Applied DNA Sciences's reported EPS has stacked up against analyst estimates in the past:

Stock Performance

Shares of Applied DNA Sciences were trading at $5.84 as of December 15. Over the last 52-week period, shares are up 49.49%. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Applied DNA Sciences is scheduled to hold the call at 16:30:00 ET and can be accessed here.